Raymond James Financial Services Advisors’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,513
Closed -$124K 3444
2023
Q3
$124K Sell
4,513
-767
-15% -$24.6K ﹤0.01% 3034
2023
Q2
$184K Sell
5,280
-66
-1% -$2.29K ﹤0.01% 2953
2023
Q1
$188K Sell
5,346
-663
-11% -$23.8K ﹤0.01% 2930
2022
Q4
$209K Buy
6,009
+216
+4% +$7.6K ﹤0.01% 2840
2022
Q3
$196K Sell
5,793
-216
-4% -$8.03K ﹤0.01% 2869
2022
Q2
$208K Sell
6,009
-34
-0.6% -$1.26K ﹤0.01% 2850
2022
Q1
$262K Sell
6,043
-335
-5% -$14.5K ﹤0.01% 2813
2021
Q4
$316K Buy
6,378
+494
+8% +$25.6K ﹤0.01% 2677
2021
Q3
$313K Sell
5,884
-11,199
-66% -$619K ﹤0.01% 2665
2021
Q2
$989K Buy
17,083
+2,113
+14% +$120K ﹤0.01% 1949
2021
Q1
$859K Buy
14,970
+6,383
+74% +$391K ﹤0.01% 1953
2020
Q4
$497K Buy
+8,587
New +$462K ﹤0.01% 2149

Other funds holding HEAL

Raymond James Financial Services Advisors's HEAL Position: Q4 2023 in Review

Raymond James Financial Services Advisors sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q4 2023, closing a stake of 4,513 shares — an estimated $124K sold.

Raymond James Financial Services Advisors first reported a position in HEAL in Q4 2020 and held it in 12 quarters. The position peaked at $989K in Q2 2021. 43 funds tracked by Wall St. Rank hold HEAL as of Q4 2023.

  • Raymond James Financial Services Advisors reported no remaining Global X Funds Global X HealthTech ETF position as of Q4 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 4,513 Global X Funds Global X HealthTech ETF shares in Q4 2023, an estimated $124K.
  • Raymond James Financial Services Advisors first reported a position in Global X Funds Global X HealthTech ETF in Q4 2020 and held it in 12 quarters.
  • Raymond James Financial Services Advisors's Global X Funds Global X HealthTech ETF position peaked at $989K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q4 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.